Cargando…
Propranolol therapy for infantile hemangioma: our experience
OBJECTIVE: Hemangiomas are the most common benign vascular tumors of infancy. Although most infantile hemangiomas (IHs) have the ability to involute spontaneously after initial proliferation and resolve without consequence, intervention is required in a subset of IHs, which develop complications res...
Autores principales: | Zhang, Ling, Wu, Hai-Wei, Yuan, Weien, Zheng, Jia-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428756/ https://www.ncbi.nlm.nih.gov/pubmed/28507428 http://dx.doi.org/10.2147/DDDT.S134808 |
Ejemplares similares
-
Our experience with propranolol for infantile hemangioma
por: Wu, Yao, et al.
Publicado: (2023) -
Estrogen-mediated hemangioma-derived stem cells through estrogen receptor-α for infantile hemangioma
por: Zhang, Ling, et al.
Publicado: (2017) -
Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study
por: Ge, Jing, et al.
Publicado: (2016) -
Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas
por: Wu, Hai Wei, et al.
Publicado: (2018) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012)